CPI has appointed Greig Rooney as its next Chief Executive. He takes up the role on 1 December 2026, succeeding Frank Millar, and will work alongside Frank over the coming months.
Greig joined CPI’s Executive Leadership Team in January 2026 as Managing Director for Pharma and HealthTech. He brings more than 20 years of leadership experience across pharmaceuticals, vaccines and biopharmaceutical manufacturing, with a career spanning the UK, Europe and the United States.
Before joining CPI, Greig was Managing Director of Valneva Scotland, where he led major national and international initiatives and built high-performing teams in a highly regulated manufacturing environment. His wider career has spanned organisational transformation, manufacturing and operations, safety and quality, and commercial growth.
Commenting on his appointment, Greig Rooney said:
“It is a real privilege to be asked to lead CPI. Since joining earlier this year I have had the opportunity to work with colleagues across the organisation and with many of our customers and partners. It has reinforced for me just how important CPI is, not simply because of the technologies we work on or our ability to help develop and scale them, but because of what that work ultimately enables.
“Our work contributes to some of the biggest challenges facing the UK: strengthening national resilience and industrial capability, improving health outcomes, and helping industry develop cleaner, more efficient and more sustainable ways to manufacture for the future.
“CPI is already delivering nationally significant work across these areas, backed by exceptional people, capabilities and partnerships. Working closely with customers and partners is central to how CPI delivers that impact, and I am excited about building on that momentum and the contribution CPI can make in the years ahead.”
